Tirzepatide Peptide Powder CAS 2023788-19-2 Synthetic Peptide Lyophilized Raw Material
TDS 2098 Inquiries
2023788-19-2
Cosmetics Grade
99%
guangzhou
LSH
10 bottles/box
Yes
2026-12-05
peptides,Retatrutide,Tirzepatide,Cosmetic peptide,API polypeptide,Pharmaceutical Peptide
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.
Certificates-
TDS
Basic Info-
Product Name:
Tirzepatide
Other Name:LY3298176;
CAS No.:2023788-19-2
Molecular Formula:C225H348N48O68
Molecular Weight:4813
EC Number:200-001-8
Categories:
Characteristics-
Appearance:
White to off-white
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834 ; NCT03987919 ; NCT03882970 ; NCT03730662 ; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptides,Retatrutide,Tirzepatide,Cosmetic peptide,API polypeptide,Pharmaceutical Peptide
-
Location:
Room 103, Building A19, Jixiangyuan, Tongzhou District, Beijing
-
Payment Terms:
D/P,TT against B/L draft before shipment
-
Average lead Time:
10 days
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
51-100
-
Year of Establishment:
2026
-
-
Inquiry History2098 Inquiries
Country Product Purchase Quantity Date Posted
Slovakia
Tirzepatide
20 MG Nov 5, 2026
Malaysia
tirzepatide
10 MG Nov 5, 2026
United Kingdom
Tirzepatide
300 MG Nov 4, 2026
South Africa
Tirzepatide
50 MG Nov 4, 2026
United States
Tirzepatide
1 G Nov 4, 2026
United States
tirzepatide
30 MG Nov 3, 2026
United States
tirzepatide
30 MG Nov 3, 2026
United Kingdom
Tirzepatide
60 MG Nov 3, 2026
Germany
Tirzeptide
1 MG Nov 2, 2026
Mexico
Tirzepatide
10 G Nov 2, 2026
United States
Tirzepatide
2 MT Nov 2, 2026
United States
tirzepatide
10 MG Oct 30, 2026
Brazil
Tirzepatide
100 G Oct 28, 2026
Belgium
Tirzepatide
10 MG Oct 28, 2026
United States
tirzepatide
100 MG Oct 28, 2026
United States
Tirzepatide
60 MG Oct 28, 2026
United States
Tirzepatide
10 PCS Oct 28, 2026
United States
tirzepatide
30 MG Oct 27, 2026
United States
Tirzepatide
40 MG Oct 27, 2026
Philippines
Tirzepatide
2 MT Oct 27, 2026 Post an enquiry for this product
More from this Seller
-
-
-
SS-31 Mitochondrial Peptide for Cellular Biology Studies and Experimental Evaluation
Research Grade / 99%
$81/MT FOB
-
-
-
-
Semax Peptide Powder ACTH 4-10 Analog CAS 80714-61-0 Lyophilized Synthetic Peptide Material
Research Grade / 99%
$54/UNIT FOB
-
-
-
-
High Purity Epithalon Synthetic Peptide AEDG CAS 307297-39-8 Freeze Dried Peptide Powder
Research Grade / 99%
$41/UNIT FOB
-
-
-
-
KPV Peptide Powder Raw Material for Laboratory Studies and Pharmaceutical Research Applications
Research Grade / 99%
$40/UNIT FOB
-
-
-
-
IGF-1 LR3 Long Acting Peptide Analog for Scientific Evaluation and Experimental Research
Research Grade / 99%
$110/MT FOB
-
